(Q38484090)

3 September 2017

1 reference

title

Antibody testing in aspergillosis--quo vadis? (English)

1 reference

3 September 2017

0 references

Iain D Page

1

0 references

author name string

Malcolm Richardson

series ordinal

2

1 reference

PubMed ID

25980000

3 September 2017

David W Denning

series ordinal

3

1 reference

3 September 2017

14 May 2015

1 reference

3 September 2017

1 reference

3 September 2017

53

1 reference

3 September 2017

5

1 reference

3 September 2017

417-439

1 reference

The clinical spectrum of pulmonary aspergillosis

3 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

The invasive and saprophytic syndromes due to Aspergillus spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Allergic bronchopulmonary aspergillosis and related allergic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Clinical characteristics and treatment outcomes of chronic necrotizing pulmonary aspergillosis: a review of 43 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Clinical characteristics and prognosis of chronic pulmonary aspergillosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Clinical characteristics and treatment outcomes of chronic pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with acute severe asthma in a respiratory intensive care unit in North India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

The emerging epidemiology of mould infections in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Global burden of chronic pulmonary aspergillosis complicating sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Surgical treatment for pulmonary aspergilloma: a 35-year experience in the Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Itraconazole in chronic cavitary pulmonary aspergillosis: a randomised controlled trial and systematic review of literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Results of surgery for chronic pulmonary Aspergillosis, optimal antifungal therapy and proposed high risk factors for recurrence--a National Centre's experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Laboratory diagnosis of invasive aspergillosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Detection of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Molecular and nonmolecular diagnostic methods for invasive fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Epidemiology of nosocomial fungal infections: invasive aspergillosis and the environment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Outdoor environmental levels of Aspergillus spp. conidia over a wide geographical area

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Mycotic keratitis: epidemiology, diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Fungal malignant otitis externa: pitfalls, diagnosis, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Airway and parenchymal manifestations of pulmonary aspergillosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Evaluation of a recombinant antigen-based enzyme immunoassay for the diagnosis of noninvasive aspergillosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Aspergillus bronchitis without significant immunocompromise.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Fungal rhinosinusitis: a categorization and definitional schema addressing current controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Invasive aspergillosis in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Ulcerative and plaque-like tracheobronchitis due to infection with Aspergillus in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Epidemiology of invasive aspergillosis in France: a six-year multicentric survey in the Greater Paris area

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Current approaches to diagnosis and treatment of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Spectrum of Aspergillus infection in lung transplant recipients: case series and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Chronic pulmonary aspergillosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Pulmonary aspergillosis in the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Good long-term outcomes after surgical treatment of simple and complex pulmonary aspergilloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Surgery for pulmonary aspergilloma in immunocompetent patients: no benefit from adjuvant antifungal pharmacotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Efficacy and safety of posaconazole for chronic pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Serum galactomannan antigen test for the diagnosis of chronic pulmonary aspergillosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

High-frequency triazole resistance found In nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Diagnostic performance of various tests and criteria employed in allergic bronchopulmonary aspergillosis: a latent class analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Sensitisation to airborne moulds and severity of asthma: cross sectional study from European Community respiratory health survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

The link between fungi and severe asthma: a summary of the evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: The Fungal Asthma Sensitization Trial (FAST) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Novel immunologic classification of aspergillosis in adult cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Clinical significance of hyperattenuating mucoid impaction in allergic bronchopulmonary aspergillosis: an analysis of 155 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Surface hydrophobin prevents immune recognition of airborne fungal spores

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Innate immunity to Aspergillus species

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Measurement of humoral antibodies to aspergilli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Performance of two Aspergillus IgG EIA assays compared with the precipitin test in chronic and allergic aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Association of presence of Aspergillus antibodies with hemoptysis in patients with old tuberculosis or bronchiectasis but no radiologically visible mycetoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Serologic diagnosis of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis through the detection of immunoglobulin G to Aspergillus fumigatus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Analysis of HIV seropositive thalassemic children for antibodies specific to Aspergillus fumigatus by luminescent immunoassay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Immunoblot analysis of serological responses in invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Use of recombinant mitogillin for improved serodiagnosis of Aspergillus fumigatus-associated diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Serum IgG responses against Aspergillus proteins before hematopoietic stem cell transplantation or chemotherapy identify patients who develop invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Isolation of Aspergillus species from the airway of lung transplant recipients is associated with excess mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

IgG enzyme linked immunosorbent assay for diagnosis of invasive aspergillosis: retrospective study over 15 years of transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Follow-up of anti-Aspergillus IgG and IgA antibodies in bone marrow transplanted patients with invasive aspergillosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Detection of Circulating Aspergillus fumigatus Galactomannan: Value and Limits of the Platelia Test for Diagnosing Invasive Aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

DIAGNOSTIC PRECIPITIN TEST IN ASPERGILLUS PULMONARY MYCETOMA

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Serologic monitoring of disease and treatment in a patient with pulmonary aspergilloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

The efficacy and tolerability of voriconazole in the treatment of chronic cavitary pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Allergic fungal rhinosinusitis: diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Allergic fungal sinusitis: pathophysiology, diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

The assessment of immunologic and clinical changes occurring during corticosteroid therapy for allergic bronchopulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Adjunctive Therapy of Allergic Bronchopulmonary Aspergillosis with Itraconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Antigen-antibody reactions in gels

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

IgM in microbial infections: taken for granted?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Rapid enzyme-linked immunosorbent assay (ELISA) for Aspergillus fumigatus antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Immunodiagnosis of aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Immuno-reactive molecules identified from the secreted proteome of Aspergillus fumigatus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Aspergillus antigens: which are important?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Genomic analysis of allergen genes in Aspergillus spp: the relevance of genomics to everyday research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Disease-specific recombinant allergens for the diagnosis of allergic bronchopulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Rapid identification of allergen-encoding cDNA clones by phage display and high-density arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Identification of 16, 18, and 45 kd antigens recognized by human IgG and IgE antibodies and murine monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Comparative genomics of fungal allergens and epitopes shows widespread distribution of closely related allergen and epitope orthologues

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Specific antibodies to recombinant allergens of Aspergillus fumigatus in cystic fibrosis patients with ABPA

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Fungal antigens expressed during invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Evaluation of Methods to Detect Antibodies against Aspergillus fumigatus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Detection of Aspergillus fumigatus precipitins: a comparison of counter immunoelectrophoresis and double diffusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Precipitins and specific IgG antibody to Aspergillus fumigatus in a chest unit population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Immunological study of pulmonary aspergilloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Studies in chronic allergic bronchopulmonary aspergillosis. 3. Immunological findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Between-laboratory quality control of automated analysis of IgG antibodies against Aspergillus fumigatus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Evaluating the Response of Patients Undergoing Both Allergy Skin Testing and in Vitro Allergy Testing With the ImmunoCAP Technology System

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Comparison of skin prick tests with specific serum immunoglobulin E in the diagnosis of fungal sensitization in patients with severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Accuracy of IgE antibody laboratory results

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

A rapid review of rapid HIV antibody tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Update on rapid diagnostic testing for malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Development of an immunochromatographic lateral-flow device for rapid serodiagnosis of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Comparison of a novel Aspergillus lateral-flow device and the Platelia® galactomannan assay for the diagnosis of invasive aspergillosis following haematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Comparison of lateral flow technology and galactomannan and (1->3)-beta-D-glucan assays for detection of invasive pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the Transplant-Associated Infection Surveillance Network.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Fungal rhinosinusitis: a prospective study in a University hospital of Uttar Pradesh

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Allergic Bronchopulmonary Aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Immune Sensing of Aspergillus fumigatus Proteins, Glycolipids, and Polysaccharides and the Impact on Th Immunity and Vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

Immunological Aspects of Allergic Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV020

21 January 2018

Identifiers

DOI

10.1093/MMY/MYV020

1 reference

3 September 2017

1 reference

PubMed ID

25980000